Shirley Brady 4

4 · Enovis CORP · Filed Mar 1, 2023

Form 4

Period: 2023-02-27

Director

Transactions

Award
Common stock, par value $0.001
2023-02-28+12,095→ 64,088 total
Award
Employee stock option (right to buy(
2023-02-28+28,681→ 28,681 total
Exercise: $57.62Exp: 2030-02-27→ Common stock, par value $0.001 (28,681 underlying)
Sale
Common stock, par value $0.001
2023-02-27$56.07/sh−8,156$457,307→ 51,993 total
Award
Common stock, par value $0.001
2023-02-27+13,416→ 60,149 total

Footnotes (4)

[F1]Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022.
[F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and deliver of certain restricted stock units and performance-based restricted units.
[F3]This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
[F4]The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file